Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis
Journal of Clinical Investigation · 15.08.2025 · 135 (16)
DOI: 10.1172/jci181034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 19.06.2025. Verfasst von Alice Horisberger und 53 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Immunophenotyping, Kidney, Lupus Nephritis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Lupus nephritis (LN) is a frequent manifestation of systemic lupus erythematosus, and fewer than half of patients achieve complete renal response with standard immunosuppressants. Identifying noninvasive, blood-based immune alterations associated with renal injury could aid therapeutic decisions. Here, we used mass cytometry immunophenotyping of peripheral blood mononuclear cells in 145 patients with biopsy-proven LN and 40 healthy controls to evaluate the heterogeneity of immune activation and identify correlates of renal parameters. Unbiased analysis identified 3 immunologically distinct groups of patients that were associated with different patterns of histopathology, renal cell infiltrates, urine proteomic profiles, and treatment response at 1 year. Patients with enriched circulating granzyme B + T cells showed more active disease and increased numbers of activated CD8 + T cells in the kidney, yet they had the highest likelihood of treatment response. A second group characterized by a high type I interferon signature had a lower likelihood of response to therapy, while a third group appeared immunologically inactive but with chronic renal injuries. The major immunologic axes of variation could be distilled down to 5 simple cytometric parameters that recapitulate several clinical associations, highlighting the potential for blood immunoprofiling to translate to clinically useful noninvasive metrics to assess immune-mediated disease in LN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
- The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, USA.
- Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- School of Public Health and.
- School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Förderung
- NIAMS NIH HHS
- NCATS NIH HHS
- National Institutes of Health
Zitieren
APA
Horisberger, A., Griffith, A., Keegan, J., Arazi, A., Pulford, J., Murzin, E., Howard, K., Hancock, B., Fava, A., Sasaki, T., Ghosh, T., Inamo, J., Beuschel, R., Cao, Y., Preisinger, K., Gutierrez-Arcelus, M., Eisenhaure, T. M., Guthridge, J., Hoover, P. J., …, & Rao, D. A. (2025). Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis. Journal of Clinical Investigation, 135(16). https://doi.org/10.1172/jci181034
Vancouver
Horisberger A, Griffith A, Keegan J, Arazi A, Pulford J, Murzin E, et al. Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis. Journal of Clinical Investigation. 2025;135(16). doi:10.1172/jci181034
BibTeX
@article{Horisberger2025,
author = {Horisberger, Alice and Griffith, Alec and Keegan, Joshua and Arazi, Arnon and Pulford, John and Murzin, Ekaterina and Howard, Kaitlyn and Hancock, Brandon and Fava, Andrea and Sasaki, Takanori and Ghosh, Tusharkanti and Inamo, Jun and Beuschel, Rebecca and Cao, Ye and Preisinger, Katie and Gutierrez-Arcelus, Maria and Eisenhaure, Thomas M and Guthridge, Joel and Hoover, Paul J and Dall'Era, Maria and Wofsy, David and Kamen, Diane L and Kalunian, Kenneth C and Furie, Richard and Belmont, Michael and Izmirly, Peter and Clancy, Robert and Hildeman, David and Woodle, E Steve and Apruzzese, William and McMahon, Maureen A and Grossman, Jennifer and Barnas, Jennifer L and Payan-Schober, Fernanda and Ishimori, Mariko and Weisman, Michael and Kretzler, Matthias and Berthier, Celine C and Hodgin, Jeffrey B and Demeke, Dawit S and Putterman, Chaim and Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Network, Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Network and Brenner, Michael B and Anolik, Jennifer H and Raychaudhuri, Soumya and Hacohen, Nir and James, Judith A and Davidson, Anne and Petri, Michelle A and Buyon, Jill P and Diamond, Betty and Zhang, Fan and Lederer, James A and Rao, Deepak A},
title = {Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {16},
doi = {10.1172/jci181034}
}
EUVIMED